In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CardioThoracic Systems Inc.

Division of Boston Scientific Corp.

Latest From CardioThoracic Systems Inc.

Back Behind the Inventor's Bench: An Interview with Tom Fogarty

The dean of device physician-entrepreneurs is launching a new crop of start-ups. Here Thomas Fogarty, MD, a cardiovascular surgeon and the entrepreneur behind more than 30 device companies, talks about the current key issues in device company creation.
Medical Device Business Strategies

Arbor Surgical Technologies Inc.

Arbor Surgical Technologies Inc. is gunning for its share of the $1-billion cardiac surgery market with two distinct technologies: a proprietary bovine pericardial heart valve and a unique surgical implantation system, which combine to form a complete platform designed to simplify valve replacement surgery.
Medical Device Platform Technologies

Keys To Creating Value for Early-Stage Medical Device Companies

Small cap firms that reach a successful exit via M&A tend to share a set of chacteristics that enable significant value creation. Start-ups can use them as a template to gauge their own potential for success. Indeed, those characteristics, which include the development of a novel, best-in-breed technology with significant clinical impact, having a set of products that deliver a competitive edge, and careful execution of their respective business plans (including managing capital and timelines), can serve as a template for early-stage medical device companies, and help define the parameters necessary for them to engineer their way towards an outcome that maximizes value.
Business Strategies Business Strategies

Fogarty and Three Arch Split Over IP Royalty Dispute

Embroiled in a dispute over intellectual property royalties, physician/inventor/entrepreneur Thomas Fogarty, MD, and Three Arch Partners, the venture firm he co-founded in 1993, have parted company.
Business Strategies Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Richard M Ferrari, Pres., CEO & Dir.
    Steve M Van Dick, VP, Fin. & Admin., CFO
    Richard A Lotti, VP, Bus. Dev
    Geoff D Dillon, VP, Global Sales
    Jeffrey G Gold, EVP & COO
  • Contact Info
  • CardioThoracic Systems Inc.
    Phone: (408) 342-1700
    10600 North Tantau Ave.
    Cupertino, CA 95014-0739